Abstract
Lipid peroxidation is one of the major outcomes of free radical-mediated injury to tissue that directly damages membranes and generates a number of secondary biologically active products. This occurs through fragmentation and rearrangement of oxygenated fatty acids that act via modification of macromolecules and activation of cell surface receptors. Numerous studies have demonstrated regionally increased brain lipid peroxidation in patients who have suffered acute brain injury from trauma or cerebrovascular disease as well as patients with protracted neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, Huntingtons disease, and human immunodeficiency virus-associated dementia. Recent studies have progressed from determining biomarkers of lipid peroxidation in tissue obtained post mortem to measuring levels in body fluids from living patients early in the course of disease. Elevated biomarkers of lipid peroxidation early in disease establish it as a potential therapeutic target and provide a novel method for following disease progression and response to therapy. Strategies for limiting the deleterious effects of lipid peroxidation include pharmacologic intervention at several points. We will present recent results from our laboratory on some of these therapeutic targets. Continuing development of pharmacologic targets and therapeutic interventions in experimental models of neurodegenerative diseases that include oxidative damage to brain may lead to effective interventions for this facet of neurodegeneration.
Keywords: lipid peroxidation, neurodegeneration, free radical-mediated injury, huntingtons disease, human immunodeficiency virus-associated dementia
Current Neuropharmacology
Title: Pharmacologic Strategies for Suppression of Lipid Peroxidation in Neurodegeneration
Volume: 1 Issue: 2
Author(s): K. S. Montine, D. Milatovic, M. Doherty, J. D. Morrow and T. J. Montine
Affiliation:
Keywords: lipid peroxidation, neurodegeneration, free radical-mediated injury, huntingtons disease, human immunodeficiency virus-associated dementia
Abstract: Lipid peroxidation is one of the major outcomes of free radical-mediated injury to tissue that directly damages membranes and generates a number of secondary biologically active products. This occurs through fragmentation and rearrangement of oxygenated fatty acids that act via modification of macromolecules and activation of cell surface receptors. Numerous studies have demonstrated regionally increased brain lipid peroxidation in patients who have suffered acute brain injury from trauma or cerebrovascular disease as well as patients with protracted neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, Huntingtons disease, and human immunodeficiency virus-associated dementia. Recent studies have progressed from determining biomarkers of lipid peroxidation in tissue obtained post mortem to measuring levels in body fluids from living patients early in the course of disease. Elevated biomarkers of lipid peroxidation early in disease establish it as a potential therapeutic target and provide a novel method for following disease progression and response to therapy. Strategies for limiting the deleterious effects of lipid peroxidation include pharmacologic intervention at several points. We will present recent results from our laboratory on some of these therapeutic targets. Continuing development of pharmacologic targets and therapeutic interventions in experimental models of neurodegenerative diseases that include oxidative damage to brain may lead to effective interventions for this facet of neurodegeneration.
Export Options
About this article
Cite this article as:
Montine S. K., Milatovic D., Doherty M., Morrow D. J. and Montine J. T., Pharmacologic Strategies for Suppression of Lipid Peroxidation in Neurodegeneration, Current Neuropharmacology 2003; 1 (2) . https://dx.doi.org/10.2174/1570159033477170
DOI https://dx.doi.org/10.2174/1570159033477170 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
Call for Papers in Thematic Issues
Advances in Neuroinflammation and Neuroprotection: Mechanisms and Therapeutic Frontiers
It offers a comprehensive exploration of neuroinflammatory and neuroprotective pathways that play central roles in a range of neurological disorders, including stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This issue invites research on the cellular and molecular mechanisms driving neuroinflammation, such as the roles of ...read more
Advances in paediatric and adult brain cancers: emerging targets and treatments
Brain tumors are the most common solid tumors affecting children and adolescents, with up to 5,000 children diagnosed per year. Pediatric brain tumors, because of their location, are often untreatable and their clinical management can cause significant long-term impairment to intellectual and neurological function with epilepsy and neurodegeneration. Other than ...read more
Emotion (Dys)regulation: An integration of Pharmacological, Neurobiological, and Psychological Frameworks
Emotion regulation is a critical aspect of mental well-being and interpersonal relationships. To fully understand and effectively address emotion regulation, an integrative approach that considers pharmacological, neurobiological, and psychological frameworks is essential. Pharmacological interventions, such as medications targeting neurotransmitter imbalances, can play a significant role in managing emotional dysregulation. Understanding ...read more
Intercellular Communications in Cerebral Ischemia
Cerebral ischemia, a condition in which there is inadequate blood supply to the brain, ranks as one of the leading causes of disability and mortality globally. Despite its prevalence and severity, efficacious treatment options for this debilitating disorder remain limited. Recent scientific explorations have delved deeply into the pathological mechanisms ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurotrophin-3 Stimulates Migration of Mesenchymal Stem Cells Overexpressing TrkC
Current Medicinal Chemistry Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology A Role for Calcineurin in Alzheimers Disease
Current Neuropharmacology Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology Trajectories of Age-Related Cognitive Decline and Potential Associated Factors of Cognitive Function in Senior Citizens of Beijing
Current Alzheimer Research TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches
CNS & Neurological Disorders - Drug Targets Neuropsychiatric Symptoms and Functional Status in Alzheimer’s Disease and Vascular Dementia Patients
Current Alzheimer Research HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer's Disease
Current Pharmaceutical Design Resveratrol and Analogues: A Review of Antioxidant Activity and Applications to Human Health
Recent Patents on Food, Nutrition & Agriculture Near-Infrared Spectroscopy (NIRS): A Non-Invasive In Vivo Methodology for Analysis of Brain Vascular and Metabolic Activities in Real Time in Rodents
Current Vascular Pharmacology Nanoparticle-Encapsulated Bryostatin-1 Activates α-Secretase and PKC Isoforms In vitro and Facilitates Acquisition and Retention of Spatial Learning in an Alzheimer's Disease Mouse Model
Current Alzheimer Research Neuronal and Glial Cell Abnormality as Predictors of Progression of Diabetic Retinopathy
Current Pharmaceutical Design Synthesis, Molecular Docking and Antiamnesic Activity of Selected 2- Naphthyloxy Derivatives
Medicinal Chemistry Dementia from a Childs Perspective
Current Aging Science Spirituality and Religion-Relevance and Assessment in the Clinical Setting
Current Psychiatry Research and Reviews Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity
Current Drug Therapy Association Between Oxidative Stress and Altered Cholesterol Metabolism in Alzheimer’s Disease Patients
Current Alzheimer Research CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Current Medicinal Chemistry - Central Nervous System Agents New Agents Promote Neuroprotection in Parkinson’s Disease Models
CNS & Neurological Disorders - Drug Targets